Three-dimensional high-definition exoscope (Kestrel View II) in anterior cervical discectomy and fusion: a valid alternative to operative microscope-assisted surgery

医学 颈椎前路椎间盘切除融合术 外科 可视模拟标度 围手术期 骨科手术 颈椎
作者
Yawei Yao,Chengjie Xiong,Tanjun Wei,Zhipeng Yao,Fangqiang Zhu,Feng Xu
出处
期刊:Acta neurochirurgica [Springer Science+Business Media]
卷期号:163 (12): 3287-3296 被引量:10
标识
DOI:10.1007/s00701-021-04997-8
摘要

Operative microscope (OM) has greatly advanced modern spine surgery, but remains limited by several drawbacks. Therefore, a three-dimensional (3D) high-definition (HD) exoscope (EX) (Kestrel View II, Mataka Kohli, Japan) system has been developed and used as an alternative to the OM. The aim of this study was to assess and compare the perioperative data and clinical outcomes of anterior cervical discectomy and fusion (ACDF) procedure with either an EX or OM. Forty-eight patients with cervical spondylotic myelopathy (CSM) underwent ACDF assisted by the EX or OM between January 2019 and December 2019. We collected and compared data on operative time, intraoperative bleeding, postoperative hospitalization stay, complications, and clinical outcomes between the two groups. The clinical outcomes were evaluated by using visual analogue scale (VAS) scores, Japanese Orthopedic Association (JOA) scores, the recovery rate of JOA scores, and Odom criteria. The operative time in the EX group was significantly shorter than that in the OM group (P < 0.05). The VAS and JOA scores were significantly improved in both groups after surgery (P < 0.05). In addition, the VAS scores in the EX group were significantly lower than those in the OM group at 1 week postoperatively (P < 0.05). The good-to-excellent outcome rates were 90.48 and 88.89% in the EX group and OM group, respectively, whereas the complication occurrence rates of the EX group and OM group were 4.76 and 11.11%, respectively. EX-assisted and OM-assisted ACDF resulted in similar clinical outcomes for CSM, while EX-assisted surgery may be related to a short operative time and fewer complications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
闫玉坤完成签到,获得积分10
刚刚
小武wwwww发布了新的文献求助30
刚刚
qin发布了新的文献求助10
1秒前
2秒前
安之完成签到,获得积分10
3秒前
cheng完成签到,获得积分10
3秒前
幸福诗槐完成签到,获得积分10
4秒前
mickiller完成签到,获得积分10
4秒前
Raymond完成签到,获得积分10
5秒前
默存完成签到,获得积分0
7秒前
7秒前
世上僅有的榮光之路完成签到,获得积分0
7秒前
Zoe完成签到,获得积分10
8秒前
zyueyun发布了新的文献求助30
8秒前
树袋熊发布了新的文献求助10
8秒前
科研通AI6.4应助使徒猫采纳,获得10
9秒前
调皮的笑阳完成签到 ,获得积分10
11秒前
慕青应助开心的秋采纳,获得10
11秒前
hyl-tcm完成签到,获得积分10
11秒前
LYQ完成签到 ,获得积分10
14秒前
大盘菜完成签到,获得积分10
14秒前
蛎卡奔发布了新的文献求助10
14秒前
yh完成签到,获得积分10
14秒前
ming830完成签到,获得积分10
15秒前
Nyuki完成签到,获得积分10
16秒前
番茄黄瓜芝士片完成签到 ,获得积分10
16秒前
zt完成签到,获得积分10
17秒前
闫永娟完成签到 ,获得积分10
17秒前
18秒前
胡江完成签到 ,获得积分10
19秒前
袁玥完成签到,获得积分10
19秒前
自信向梦完成签到,获得积分10
20秒前
20秒前
zyy完成签到,获得积分10
20秒前
张欢馨应助过时的亦寒采纳,获得10
20秒前
DoctorSUN完成签到,获得积分10
22秒前
蝌蚪完成签到,获得积分10
22秒前
宗剑完成签到,获得积分10
22秒前
小陶子完成签到,获得积分10
23秒前
Ada完成签到 ,获得积分10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6362286
求助须知:如何正确求助?哪些是违规求助? 8176007
关于积分的说明 17224813
捐赠科研通 5416998
什么是DOI,文献DOI怎么找? 2866674
邀请新用户注册赠送积分活动 1843775
关于科研通互助平台的介绍 1691614